#AI #Health #Stock News -GBT (OTC: $GTCH) introduces Generation II of its qTerm;
#artificialintelligence
qTerm’s second release includes body temperature,
blood oxygen and heart rate vitals with higher stability, and consistency to
cover wider spectrum of users measurement habits
San Diego, CA, May 26, 2021 - (Investorideas.com Newswire) GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”) via GBT Tokenize Corp, completed generation II of its qTerm device. The GEN II release is a second version that includes a series of enhancements that target higher measurement accuracy, reliability and compatibility with a broader spectrum of users usage behavior. GBT's qTerm, a human vitals intelligent device is aimed to measure human vitals with a touch of a finger. Based on GEN I prototype testing, debugging and study, GBT’s concluded GEN II version to significantly advance the device’s general population compatibility. qTerm’s second release includes body temperature, blood oxygen and heart rate vitals with higher stability, and consistency to cover wider spectrum of users measurement habits. The device’s sensors were physically re-located to more efficient positions to enable best and consistent results.
An additional coprocessor chip was installed to
provide an advanced adjusting algorithm to support broader user’s measuring
habits, compensating for different inputs and providing consistent results.
Similar to the GEN I version, the GEN II device will be accompanied by a
smartphone app and synchronized web application to keep a history and provide
analytics for user's records at a later phase. The web application will be
providing a geographical location and proximity alert to assist with potential
health risks. GEN II series of modifications are done as part of the Company’s
preparations for an FDA certification to classify qTerm as a medical device to
be marketed and sold in the US. The certification process will be also aimed to
define the device for telemedicine purposes enabling remote vitals results to
be sent to clinics and hospitals for physicians review in real time. qTerm’s
GEN II device is currently under testing for technical performance and
commercial look-and-feel features evaluation.
Read
this news, featuring GTCH in full at https://www.investorideas.com/CO/GOPH/news/2021/05261Generation-II-qTerm.asp
"We are proud to announce the completion of
our Gen II qTerm human vital device. We implemented a series of improvements in
qTerm’s second release to achieve higher performance, accuracy, and user’s
compatibility level. We put extra emphasis on the device ease of use, and user
friendliness aspects. The device is currently under technical performance
testing and commercial features look-and-feel evaluations. We strongly believe
that qTerm can be an efficient, affordable health device in every household to
assist with general health monitoring and early detection of symptoms and
concerns. We are ever thriving to improve the device’s performance and
capabilities, bringing it to the highest standards and regulations to enable
people maintaining healthy life style." stated Danny Rittman, the Company’s
Chief Technology Officer.
There
is no guarantee that the Company will be successful in researching, developing
or implementing this system. In order to
successfully implement this concept, the Company will need to raise adequate
capital to support its research and, if successfully researched, developed and
granted regulatory approval, the Company would need to enter into a strategic
relationship with a third party that has experience in manufacturing, selling
and distributing this product. There is
no guarantee that the Company will be successful in any or all of these
critical steps.
About Us
GBT
Technologies, Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com)
is a development stage company which considers itself a native of Internet of
Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology
Platforms used to increase IC performance. GBT has assembled a team with
extensive technology expertise and is building an intellectual property
portfolio consisting of many patents. GBT’s mission, to license the technology
and IP to synergetic partners in the areas of hardware and software. Once
commercialized, it is GBT’s goal to have a suite of products including smart
microchips, AI, encryption, Blockchain, IC design, mobile security
applications, database management protocols, with tracking and supporting cloud
software (without the need for GPS). GBT envisions this system as a creation of
a global mesh network using advanced nodes and super performing new generation
IC technology. The core of the system will be its advanced microchip
technology; technology that can be installed in any mobile or fixed device
worldwide. GBT’s vision is to produce this system as a low cost, secure,
private-mesh-network between any and all enabled devices. Thus, providing
shared processing, advanced mobile database management and sharing while using
these enhanced mobile features as an alternative to traditional carrier services.
Forward-Looking Statements
Certain
statements contained in this press release may constitute "forward-looking
statements". Forward-looking statements provide current expectations
of future events based on certain assumptions and include any statement that
does not directly relate to any historical or current fact. Actual results may
differ materially from those indicated by such forward-looking statements as a
result of various important factors as disclosed in our filings with the
Securities and Exchange Commission located at their website ( http://www.sec.gov). In addition to these
factors, actual future performance, outcomes, and results may differ materially
because of more general factors including (without limitation) general industry
and market conditions and growth rates, economic conditions, governmental and
public policy changes, the Company’s ability to raise capital on acceptable
terms, if at all, the Company’s successful development of its products and the
integration into its existing products and the commercial acceptance of the
Company’s products. The forward-looking statements included in this press
release represent the Company's views as of the date of this press release and
these views could change. However, while the Company may elect to update
these forward-looking statements at some point in the future, the Company
specifically disclaims any obligation to do so. These forward-looking
statements should not be relied upon as representing the Company's views as of
any date subsequent to the date of the press release.
Contact:
Dr.
Danny Rittman, CTO
press@gopherprotocol.com
GBT Technologies Inc.
(OTCQB:GTCH) is a featured tech stock on
More info on GTCH at
Investorideas.com Visit: https://www.investorideas.com/CO/GOPH/
Get News Alerts on GBT Technologies Inc GTCH
Disclaimer/Disclosure: Investorideas.com
is a digital publisher of third party sourced news, articles and equity
research as well as creates original content, including video, interviews and
articles. Original content created by investorideas is protected by copyright
laws other than syndication rights. Our site does not make recommendations for
purchases or sale of stocks, services or products. Nothing on our sites should
be construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Disclosure: GTCH is a PR, social media and publishing client and
compensates Investorideas.com https://www.investorideas.com/About/News/Clientspecifics.asp
Contact management and IR of each company directly
regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the Investorideas.com
newswire https://www.investorideas.com/News-Upload/
and tickertagstocknews.com Global
investors must adhere to regulations of each country. Please read
Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Get more tech stocks investor ideas- news, articles, podcasts and stock directories